HDR Endorectal Brachytherapy With 3D-Printed Guidance and Local Shielding for Rectal Cancer Organ Preservation | MicrobiomeTrials← Back to trialsNCT07786493
HDR Endorectal Brachytherapy With 3D-Printed Guidance and Local Shielding for Rectal Cancer Organ Preservation
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-09-01Est. Completion: 2029-11-30
Enrollment target: 50 participants Locations- Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, China
Other microbiome trials you might be interested in
Oesophageal Squamous Cell CarcinomaOesophageal AdenocarcinomaGastric AdenocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)CholangiocarcinomaHepatocellular Carcinoma (HCC)Colorectal Adenocarcinoma
The investigators of this study are developing a simple breath test to help detect gastrointestinal (gut) cancers earlie…
Maidstone, United KingdomEst. completion Feb 2, 2028
Cancer
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerab…
Tucson, United States
Est. completion Jun 1, 2027